Cullinan Therapeutics, Inc.

Healthcare

NASDAQ:CGEM · NASDAQ Global Select

Market Cap $841.97M Beta 0.01 P/E (TTM) -3.7

$13.70 +5.55%

+$0.72 today

52W Low $5.68High $16.74

Vol 1.31M · Avg 0.93M

EPS (TTM)-$3.73

Medical - Pharmaceuticals

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+59.12%

Period High

$16.44

Period Low

$5.75

Latest

$13.70

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

RAPT Therapeutics, Inc.

RAPT

$959.26M

Enhabit, Inc.

EHAB

$706.91M

CeriBell, Inc.

NASDAQ:CBLL

$700.80M

Omeros Corporation

NASDAQ:OMER

$632.20M

Varex Imaging Corporation

NASDAQ:VREX

$464.78M

Standard BioTools Inc.

NASDAQ:LAB

$346.53M

Neumora Therapeutics, Inc. Common Stock

NASDAQ:NMRA

$329.81M

Bicycle Therapeutics plc

NASDAQ:BCYC

$281.05M

So-Young International Inc.

NASDAQ:SY

$244.05M

ADC Therapeutics S.A.

NYSE:ADCT

$133.55M

What is the latest CGEM filing?

The latest filing shown is 8-K dated Jun 10, 2026.

How many recent filings does CGEM have?

Intrinsic Alpha currently shows 20 recent filings for CGEM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.